암 면역치료 시장 : 치료 유형별, 투여 경로별, 암 유형별, 유통 채널별, 지역별
Cancer Immunotherapy Market, By Therapy Type, By Route of Administration, By Cancer Type, By Distribution Channel, By Geography
상품코드
:
1672654
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 암 면역치료 시장은 2025년에 1,584억 2,000만 달러로 추정되며, 2032년에는 3,570억 7,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 12.3%로 성장할 것으로 예측됩니다.
| 보고 범위 |
보고서 상세 내용 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
1,584억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간: 2025-2032년 CAGR: |
12.30% |
2032년 가치 예측 |
3,570억 7,000만 달러 |
도표. 2025년 지역별 암 면역요법 시장 점유율(%), 지역별
암 면역 요법은 암과 싸우기 위해 신체의 면역 체계를 이용하는 암 치료의 일종입니다. 면역체계의 힘을 이용하여 암에 대한 신체의 자연적 방어력을 강화하기 위해 면역체계를 수정하는 혁신적인 접근법입니다. 암 면역치료는 모노클로널 항체, 체크포인트 억제제, 인터류킨 억제제, 치료용 암 백신 등의 치료법으로 구성되어 있습니다. 최근 과학의 발전으로 종양세포와 면역체계의 복잡한 상호작용에 대한 이해가 깊어짐에 따라 주목받고 있습니다. 암 면역치료는 미래의 암 치료법을 크게 변화시킬 수 있는 새로운 치료 패러다임입니다.
시장 역학:
세계 암 면역치료 시장의 성장은 전 세계 암 발병률 증가, 효과적인 표적치료에 대한 수요 증가, 기존 치료법에 비해 암 면역치료와 관련된 높은 치료 성공률 등의 요인에 의해 주도되고 있습니다. 암은 여전히 주요 사망 원인 중 하나이며, 가까운 미래에 암으로 인한 전 세계 사망자 수는 크게 증가할 것으로 예상됩니다. 이는 면역치료의 채택에 큰 동력이 되고 있습니다. 바이오테크놀러지의 발전과 암 면역학에 대한 이해의 진전으로 새로운 면역치료제가 개발되어 환자의 예후를 개선할 수 있는 길이 열리고 있습니다. 그러나 면역치료제 관련 고가의 비용, 전문 인프라와 의료 인력의 필요성, 면역치료제 관련 안전성 우려 등이 시장 성장을 저해하는 요인으로 작용하고 있습니다. 이 분야의 활발한 연구개발, 새로운 암종을 대상으로 한 연구개발, 진행 중인 임상시험은 시장 진출기업에게 성장 기회를 제공할 수 있는 잠재력을 가지고 있습니다.
본 조사의 주요 특징
- 세계의 암 면역요법 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR%)을 게재하고 있습니다.
- 또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 암 면역요법 시장의 주요 업체를 프로파일링합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 암 면역 요법 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 암 면역요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장의 전망
- 리포트 설명
- 개요
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 최근 동향
- 인수와 제휴 시나리오
- 테크놀러지의 개요
- 규제 시나리오
- 가격 분석
- PEST 분석
제4장 세계의 암 면역치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 구상
- 시장에 대한 COVID-19의 영향
제5장 세계의 암 면역치료 시장, 치료 유형별, 2020-2032년, (10억 달러)
- 면역 체크포인트 저해제
- 백신
- 예방 백신
- 치료 백신
- 양자 세포치료
- 종양 침윤 림프구(TIL) 요법
- CAR T 세포치료
- 개변 T세포 수용체(TCR) 요법
- 천연 킬러(NK) 세포치료
- 면역 시스템 조절제
- 인터페론
- 면역 조절약(IMiD)
- 인터류킨
- 모노클로널 항체
- 알몸 모노클로널 항체
- 결합 모노클로널 항체
- 이중특이성 모노클로널 항체
- 종양용해성 바이러스 요법
제6장 세계의 암 면역치료 시장, 투여 경로별, 2020-2032년, (10억 달러)
제7장 세계의 암 면역치료 시장, 암 유형별, 2020-2032년, (10억 달러)
- 림프종
- 유방암
- 대장암
- 방광암
- 피부암
- 폐암
- 신장암
- 기타
제8장 세계의 암 면역치료 시장, 유통 채널별, 2020-2032년, (10억 달러)
제9장 세계의 암 면역치료 시장, 지역별, 2020-2032년, (10억 달러)
중동
제10장 경쟁 구도
- 기업 개요
- Gilead Sciences, Inc.
- Johnson &Johnson
- Actym Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck &Co., Inc.
- Fate Therapeutics
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- BioNTech SE
- Cellectis
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- Gritstone bio
- Incyte
제11장 애널리스트의 권장사항
- 운명의 수레바퀴
- 애널리스트의 견해
- COM(Coherent Opportunity Map)
제12장 참고 문헌과 조사 방법
KSA
영문 목차
Global Cancer Immunotherapy Market is estimated to be valued at USD 158.42 Bn in 2025 and is expected to reach USD 357.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 158.42 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
12.30% |
2032 Value Projection: |
USD 357.07 Bn |
Figure. Cancer Immunotherapy Market Share (%), By Region 2025
Cancer immunotherapy is a type of cancer treatment that utilizes the body's own immune system to fight against cancer. It is an innovative approach that harnesses the power of the immune system and modifies it to enhance the body's natural defenses against cancer. Cancer immunotherapy comprises therapies like monoclonal antibodies, checkpoint inhibitors, interleukin inhibitors, therapeutic cancer vaccines and others. It is gaining prominence as recent scientific breakthroughs have improved understanding of the complex interaction between tumor cells and the immune system. Cancer immunotherapy represents a novel treatment paradigm that has the potential to transform the way cancer is treated in the future.
Market Dynamics:
Global cancer immunotherapy market growth is driven by factors such as increasing prevalence of cancer worldwide, rising demand for effective targeted therapies, and higher treatment success rates associated with cancer immunotherapy as compared to conventional treatment modalities. Cancer remains one of the leading causes of mortality and the global burden of cancer is expected to rise significantly in the near future. This is providing a major boost to immunotherapy adoption. Advancements in biotechnology along with better understanding of cancer immunology have led to the development of novel immunotherapies, which are paving the way for improved patient outcomes. However, high costs associated with immunotherapy drugs, need for specialized infrastructure and healthcare personnel, and safety concerns related to immunotherapy are some of the challenges restraining the market growth. Active R&D in this field, targeting new cancer types, and ongoing clinical trials hold potential to provide growth opportunities for market players.
Key Features of the Study:
- This report provides in-depth analysis of the global cancer immunotherapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cancer immunotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Gilead Sciences, Inc., Johnson & Johnson, Actym Therapeutics, Inc., Bristol-Myers Squibb Company, Pfizer Inc, Novartis AG, Merck & Co., Inc., Fate Therapeutics., AstraZeneca, Amgen Inc., GSK plc., Acumen Pharmaceuticals, Inc, Arcus Biosciences, Inc., BioNTech SE, Cellectis, immunitybio inc, Autolus Therapeutics, ADC Therapeutics SA., Gritstone bio, and Incyte.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global cancer immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer immunotherapy market.
Detailed Segmentation-
- Therapy Type:
- Immune checkpoint inhibitors
- Vaccines
- Preventive Vaccines
- Therapeutic Vaccines
- Adoptive Cell Therapies
- Tumor-infiltrating lymphocyte (TIL) therapy
- CAR T-cell therapy
- Engineered T-cell receptor (TCR) therapy
- Natural killer (NK) cell therapy
- Immune System Modulators
- Interferons
- Immunomodulators (IMiDs)
- Interleukins
- Monoclonal antibodies
- Naked monoclonal antibodies
- Conjugated monoclonal antibodies
- Bispecific monoclonal antibodies
- Oncolytic Virus Therapy
- Route of Administration:
- Subcutaneous
- Oral
- Intramuscular
- Intravenous (IV)
- Others
- Cancer Type:
- Lymphoma
- Breast Cancer
- Colorectal Cancer
- Bladder Cancer
- Skin Cancer
- Lung Cancer
- Kidney Cancer
- Others
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- Fate Therapeutics.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- BioNTech SE
- Cellectis
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- Gritstone bio
- Incyte
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Cancer Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Cancer Immunotherapy Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Cancer Immunotherapy Market, By Therapy Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Immune checkpoint inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Preventive Vaccines
- Therapeutic Vaccines
- Adoptive Cell Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tumor-infiltrating lymphocyte (TIL) therapy
- CAR T-cell therapy
- Engineered T-cell receptor (TCR) therapy
- Natural killer (NK) cell therapy
- Immune System Modulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Interferons
- Immunomodulators (IMiDs)
- Interleukins
- Monoclonal antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Naked monoclonal antibodies
- Conjugated monoclonal antibodies
- Bispecific monoclonal antibodies
- Oncolytic Virus Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Cancer Immunotherapy Market, By Route of Administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intravenous (IV)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Cancer Immunotherapy Market, By Cancer Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bladder Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Skin Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Kidney Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Cancer Immunotherapy Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Cancer Immunotherapy Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Gilead Sciences, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- Fate Therapeutics
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- BioNTech SE
- Cellectis
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- Gritstone bio
- Incyte
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
